Literature DB >> 15619533

Laparoscopic gastric bypass for refractory morbid obesity.

Conrad H Simpfendorfer1, Samuel Szomstein, Raul Rosenthal.   

Abstract

Morbid obesity has reached epidemic proportions in the United States. Laparoscopic gastric bypass is rapidly becoming the procedure of choice for treatment of morbid obesity. Results demonstrate that the surgery is technically safe. Outcomes are similar to open gastric bypass,but with markedly lower incidences of wound-related and cardiopulmonary complications. Patients also have shorter hospital stay, decreased pain and faster recovery.

Entities:  

Mesh：

Year:  2005        PMID： 15619533     DOI： 10.1016/j.suc.2004.10.001

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  4 in total

1.  Mid-term results of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass in adolescent patients.

Authors:  Yaniv Cozacov; Mayank Roy; Savannah Moon; Pablo Marin; Emanuele Lo Menzo; Samuel Szomstein; Raul Rosenthal
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

2.  Endoscopic Closure of Gastro-gastric Fistula After Gastric Bypass: a Technically Feasible Procedure but Associated with Low Success Rate.

Authors:  Catherine Tsai; Ulf Kessler; Rudolf Steffen; Hans Merki; Joerg Zehetner
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

3.  Factors predicting the increased risk for return to the operating room in bariatric patients: a NSQIP database study.

Authors:  Kalyana Nandipati; Edward Lin; Farah Husain; Sebastian Perez; Jahnavi Srinivasan; John F Sweeney; S Scott Davis
Journal:  Surg Endosc       Date:  2012-10-18       Impact factor: 4.584

4.  Twelve year experience of laparoscopic gastric plication in morbid obesity: development of the technique and patient outcomes.

Authors:  Mohammad Talebpour; Seyed Mohammad Kalantar Motamedi; Atieh Talebpour; Hamed Vahidi
Journal:  Ann Surg Innov Res       Date:  2012-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.